Paul Tudor Jones Theravance Biopharma, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 196,578 shares of TBPH stock, worth $1.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
196,578
Previous 196,578
-0.0%
Holding current value
$1.89 Million
Previous $1.58 Million
16.73%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding TBPH
# of Institutions
129Shares Held
46.5MCall Options Held
200Put Options Held
1.2K-
Madison Avenue Partners, LP New York, NY9.51MShares$91.4 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$71.7 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$45.7 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$36.3 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$26.5 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $642M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...